nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—NR3C1—metabolic syndrome X	0.878	1	CbGaD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—HSD11B1—metabolic syndrome X	0.00777	0.0701	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—SMEK2—metabolic syndrome X	0.0076	0.0686	CbGpPWpGaD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—PLA2G4A—metabolic syndrome X	0.00326	0.0294	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—NR1H3—metabolic syndrome X	0.00278	0.025	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—NR1H3—metabolic syndrome X	0.00219	0.0198	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—PLA2G6—metabolic syndrome X	0.00214	0.0193	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—NR1I3—metabolic syndrome X	0.00203	0.0183	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—NR1I2—metabolic syndrome X	0.00186	0.0168	CbGpPWpGaD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—PTGS2—metabolic syndrome X	0.00184	0.0166	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—HDAC3—metabolic syndrome X	0.00181	0.0163	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC3—metabolic syndrome X	0.00177	0.0159	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—metabolic syndrome X	0.00175	0.0158	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—metabolic syndrome X	0.00165	0.0149	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—NR1I3—metabolic syndrome X	0.00161	0.0145	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—NR1I2—metabolic syndrome X	0.00147	0.0132	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—metabolic syndrome X	0.00141	0.0127	CbGpPWpGaD
Amcinonide—Prednisone—HSD11B1—metabolic syndrome X	0.0014	0.122	CrCbGaD
Amcinonide—NR3C1—Circadian Clock—HDAC3—metabolic syndrome X	0.00131	0.0119	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—FABP4—metabolic syndrome X	0.00131	0.0119	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—HMGCR—metabolic syndrome X	0.00126	0.0113	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—GCK—metabolic syndrome X	0.00122	0.011	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—MTNR1B—metabolic syndrome X	0.00116	0.0105	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—NR1I3—metabolic syndrome X	0.0011	0.0099	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—HTR2C—metabolic syndrome X	0.00109	0.00982	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—metabolic syndrome X	0.00109	0.0098	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—RETN—metabolic syndrome X	0.00108	0.00972	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—NR1H3—metabolic syndrome X	0.00104	0.00936	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—GHRL—metabolic syndrome X	0.00103	0.00931	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—NAMPT—metabolic syndrome X	0.00103	0.00927	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—GHRL—metabolic syndrome X	0.00102	0.00919	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—metabolic syndrome X	0.000973	0.00878	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—FMO3—metabolic syndrome X	0.000972	0.00877	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IRS1—metabolic syndrome X	0.00097	0.00875	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—metabolic syndrome X	0.000947	0.00854	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—SIRT1—metabolic syndrome X	0.000934	0.00842	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.000925	0.00835	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—metabolic syndrome X	0.000923	0.00832	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SCD—metabolic syndrome X	0.000916	0.00827	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—SREBF1—metabolic syndrome X	0.000916	0.00826	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—LEP—metabolic syndrome X	0.000897	0.00809	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CNR1—metabolic syndrome X	0.000814	0.00734	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.000774	0.00698	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—metabolic syndrome X	0.000756	0.00682	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CCL2—metabolic syndrome X	0.000754	0.0068	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCL5—metabolic syndrome X	0.000748	0.00675	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.000742	0.00669	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—PPARA—metabolic syndrome X	0.00074	0.00667	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.000721	0.0065	CbGpPWpGaD
Amcinonide—Fluocinolone Acetonide—PLA2G4A—metabolic syndrome X	0.000711	0.0621	CrCbGaD
Amcinonide—ANXA1—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.000705	0.00636	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.000683	0.00616	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—metabolic syndrome X	0.000682	0.00615	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—IRS1—metabolic syndrome X	0.000657	0.00593	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.000647	0.00584	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—AGT—metabolic syndrome X	0.000633	0.00571	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.000631	0.00569	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—AGT—metabolic syndrome X	0.000625	0.00564	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—metabolic syndrome X	0.000617	0.00557	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—PTGS2—metabolic syndrome X	0.000615	0.00555	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—PPARG—metabolic syndrome X	0.000611	0.00552	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PPARA—metabolic syndrome X	0.000585	0.00527	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TRIB3—metabolic syndrome X	0.000576	0.00519	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.000567	0.00511	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—metabolic syndrome X	0.000563	0.00508	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—PPARA—metabolic syndrome X	0.00055	0.00496	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000549	0.00495	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—metabolic syndrome X	0.000533	0.00481	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—AGT—metabolic syndrome X	0.000528	0.00476	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GHRL—metabolic syndrome X	0.00052	0.00469	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—NAMPT—metabolic syndrome X	0.000516	0.00466	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCL2—metabolic syndrome X	0.000515	0.00465	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.000504	0.00455	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—metabolic syndrome X	0.000503	0.00454	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000502	0.00452	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CNR1—metabolic syndrome X	0.000493	0.00445	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—metabolic syndrome X	0.000489	0.00441	CbGpPWpGaD
Amcinonide—Fluticasone Propionate—PLA2G4A—metabolic syndrome X	0.000486	0.0425	CrCbGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—metabolic syndrome X	0.000483	0.00436	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—HMGA1—metabolic syndrome X	0.000469	0.00423	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SREBF1—metabolic syndrome X	0.00046	0.00415	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TGFB1—metabolic syndrome X	0.000444	0.00401	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—GCK—metabolic syndrome X	0.000443	0.004	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—AGT—metabolic syndrome X	0.000439	0.00396	CbGpPWpGaD
Amcinonide—Difluprednate—NR3C1—metabolic syndrome X	0.00043	0.0376	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—ADIPOQ—metabolic syndrome X	0.000422	0.00381	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00042	0.00378	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	0.000418	0.00377	CbGpPWpGaD
Amcinonide—Prednicarbate—NR3C1—metabolic syndrome X	0.000417	0.0365	CrCbGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—metabolic syndrome X	0.000415	0.00374	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—SERPINE1—metabolic syndrome X	0.00041	0.0037	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—metabolic syndrome X	0.000406	0.00366	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SLC2A4—metabolic syndrome X	0.000399	0.0036	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000398	0.00359	CbGpPWpGaD
Amcinonide—Diflorasone—NR3C1—metabolic syndrome X	0.000395	0.0345	CrCbGaD
Amcinonide—Desonide—NR3C1—metabolic syndrome X	0.000395	0.0345	CrCbGaD
Amcinonide—Desoximetasone—NR3C1—metabolic syndrome X	0.000385	0.0336	CrCbGaD
Amcinonide—ANXA1—GPCR ligand binding—CCL5—metabolic syndrome X	0.000382	0.00345	CbGpPWpGaD
Amcinonide—Loteprednol—NR3C1—metabolic syndrome X	0.00038	0.0332	CrCbGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NR1H3—metabolic syndrome X	0.000379	0.00342	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCL2—metabolic syndrome X	0.000362	0.00326	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000362	0.00326	CbGpPWpGaD
Amcinonide—Fluoxymesterone—SHBG—metabolic syndrome X	0.000353	0.0309	CrCbGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000346	0.00312	CbGpPWpGaD
Amcinonide—Flurandrenolide—NR3C1—metabolic syndrome X	0.000337	0.0295	CrCbGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—metabolic syndrome X	0.000335	0.00302	CbGpPWpGaD
Amcinonide—Flumethasone Pivalate—NR3C1—metabolic syndrome X	0.000331	0.029	CrCbGaD
Amcinonide—Halobetasol Propionate—NR3C1—metabolic syndrome X	0.000326	0.0285	CrCbGaD
Amcinonide—Cortisone acetate—NR3C1—metabolic syndrome X	0.000321	0.0281	CrCbGaD
Amcinonide—ANXA1—GPCR ligand binding—AGT—metabolic syndrome X	0.000319	0.00288	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LPL—metabolic syndrome X	0.000313	0.00282	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00031	0.0028	CbGpPWpGaD
Amcinonide—Budesonide—NR3C1—metabolic syndrome X	0.000303	0.0265	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.000302	0.00273	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—metabolic syndrome X	0.000301	0.00271	CbGpPWpGaD
Amcinonide—Fluticasone furoate—NR3C1—metabolic syndrome X	0.000297	0.026	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000294	0.00265	CbGpPWpGaD
Amcinonide—Mometasone—NR3C1—metabolic syndrome X	0.000288	0.0252	CrCbGaD
Amcinonide—Rimexolone—NR3C1—metabolic syndrome X	0.000285	0.0249	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.000282	0.00255	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000282	0.00254	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000278	0.00251	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.000277	0.0025	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARA—metabolic syndrome X	0.000277	0.00249	CbGpPWpGaD
Amcinonide—Fluocinonide—NR3C1—metabolic syndrome X	0.000269	0.0235	CrCbGaD
Amcinonide—Beclomethasone—NR3C1—metabolic syndrome X	0.000269	0.0235	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—AGT—metabolic syndrome X	0.000268	0.00242	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GHRL—metabolic syndrome X	0.000267	0.00241	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCL2—metabolic syndrome X	0.000263	0.00237	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LEP—metabolic syndrome X	0.000262	0.00237	CbGpPWpGaD
Amcinonide—Fluocinolone Acetonide—NR3C1—metabolic syndrome X	0.000261	0.0228	CrCbGaD
Amcinonide—Fludrocortisone—NR3C1—metabolic syndrome X	0.000254	0.0222	CrCbGaD
Amcinonide—Clobetasol propionate—NR3C1—metabolic syndrome X	0.000254	0.0222	CrCbGaD
Amcinonide—Flunisolide—NR3C1—metabolic syndrome X	0.000254	0.0222	CrCbGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—metabolic syndrome X	0.000254	0.00229	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NR1I2—metabolic syndrome X	0.000254	0.00229	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CNR1—metabolic syndrome X	0.000253	0.00228	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EDC4—metabolic syndrome X	0.00025	0.00226	CbGpPWpGaD
Amcinonide—Ciclesonide—NR3C1—metabolic syndrome X	0.000247	0.0216	CrCbGaD
Amcinonide—Fluorometholone—NR3C1—metabolic syndrome X	0.000245	0.0214	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—HDAC3—metabolic syndrome X	0.000239	0.00216	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IRS1—metabolic syndrome X	0.000234	0.00211	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARG—metabolic syndrome X	0.000229	0.00206	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—INS—metabolic syndrome X	0.000224	0.00202	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—TGFB1—metabolic syndrome X	0.000218	0.00197	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IGF1—metabolic syndrome X	0.000217	0.00196	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000216	0.00195	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—metabolic syndrome X	0.000215	0.00194	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000214	0.00193	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TGFB1—metabolic syndrome X	0.000213	0.00192	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.00021	0.0019	CbGpPWpGaD
Amcinonide—Fluoxymesterone—NR3C1—metabolic syndrome X	0.00021	0.0184	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—TRIB3—metabolic syndrome X	0.000208	0.00188	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RBP4—metabolic syndrome X	0.000208	0.00188	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.000207	0.00187	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SERPINE1—metabolic syndrome X	0.000206	0.00186	CbGpPWpGaD
Amcinonide—Triamcinolone—NR3C1—metabolic syndrome X	0.0002	0.0175	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL5—metabolic syndrome X	0.000196	0.00177	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000195	0.00176	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOC3—metabolic syndrome X	0.000184	0.00166	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NR1H3—metabolic syndrome X	0.000182	0.00165	CbGpPWpGaD
Amcinonide—Prednisone—NR3C1—metabolic syndrome X	0.000181	0.0158	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—AGT—metabolic syndrome X	0.000181	0.00163	CbGpPWpGaD
Amcinonide—Fluticasone Propionate—NR3C1—metabolic syndrome X	0.000179	0.0156	CrCbGaD
Amcinonide—Prednisolone—NR3C1—metabolic syndrome X	0.000167	0.0146	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—HTR2C—metabolic syndrome X	0.000166	0.0015	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AGT—metabolic syndrome X	0.000164	0.00148	CbGpPWpGaD
Amcinonide—Betamethasone—NR3C1—metabolic syndrome X	0.000164	0.0143	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—CYBA—metabolic syndrome X	0.000161	0.00145	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—metabolic syndrome X	0.000161	0.00145	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GHRL—metabolic syndrome X	0.000158	0.00142	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CNR1—metabolic syndrome X	0.000149	0.00135	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—metabolic syndrome X	0.000142	0.00128	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000135	0.00122	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NR1I3—metabolic syndrome X	0.000134	0.0012	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—metabolic syndrome X	0.000132	0.00119	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—metabolic syndrome X	0.000131	0.00118	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TGFB1—metabolic syndrome X	0.00013	0.00117	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF2—metabolic syndrome X	0.000122	0.0011	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NR1I2—metabolic syndrome X	0.000122	0.0011	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—metabolic syndrome X	0.000121	0.00109	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOB—metabolic syndrome X	0.000119	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL5—metabolic syndrome X	0.000116	0.00104	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000115	0.00104	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—metabolic syndrome X	0.000113	0.00991	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—LPL—metabolic syndrome X	0.000113	0.00102	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.000105	0.000946	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARA—metabolic syndrome X	0.000101	0.000911	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—metabolic syndrome X	9.79e-05	0.000884	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AGT—metabolic syndrome X	9.69e-05	0.000874	CbGpPWpGaD
Amcinonide—Dexamethasone—NR3C1—metabolic syndrome X	9.52e-05	0.00832	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—APOE—metabolic syndrome X	9.49e-05	0.000856	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LEP—metabolic syndrome X	9.49e-05	0.000856	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOA1—metabolic syndrome X	9.38e-05	0.000846	CbGpPWpGaD
Amcinonide—Betamethasone—PTGS2—metabolic syndrome X	9.29e-05	0.00812	CrCbGaD
Amcinonide—Prednisone—ALB—metabolic syndrome X	9.16e-05	0.00801	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—IRS1—metabolic syndrome X	8.47e-05	0.000764	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	8.47e-05	0.000764	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARG—metabolic syndrome X	8.35e-05	0.000753	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—INS—metabolic syndrome X	8.11e-05	0.000731	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL2—metabolic syndrome X	7.98e-05	0.00072	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1—metabolic syndrome X	7.84e-05	0.000707	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	7.52e-05	0.000678	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SERPINE1—metabolic syndrome X	7.45e-05	0.000672	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOS3—metabolic syndrome X	7.11e-05	0.000641	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—metabolic syndrome X	6.09e-05	0.00055	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—metabolic syndrome X	6e-05	0.000541	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SIRT1—metabolic syndrome X	5.85e-05	0.000528	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—metabolic syndrome X	5.53e-05	0.000499	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—metabolic syndrome X	5.4e-05	0.00472	CrCbGaD
Amcinonide—NR3C1—Gene Expression—PPARA—metabolic syndrome X	4.86e-05	0.000439	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFB1—metabolic syndrome X	4.7e-05	0.000424	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPARG—metabolic syndrome X	4.02e-05	0.000362	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SERPINE1—metabolic syndrome X	3.62e-05	0.000327	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—metabolic syndrome X	3.54e-05	0.00032	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—metabolic syndrome X	3.27e-05	0.000295	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—metabolic syndrome X	1.59e-05	0.000143	CbGpPWpGaD
